Jacobs SA, Robidoux A, Abraham J, Perez-Garcia JM, et al. Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer. Breast Cancer Res 2020;22:9.
PMID: 31969184